96757 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Cyclic peptides containing only normal peptide links Cyclosporins; Related peptides
CYCLOSPORINE COMPOSITIONS AND METHODS OF USE
#2CYCLOSPORINE-ACRIDINIUM ESTERS AND METHODS OF PRODUCTION AND USE THEREOF
#3CYCLOSPORINE ANALOGUES
#4METHOD FOR PREPARING A SALT OF ISOCYCLOSPORIN A
#5IMPROVED PROCESS FOR THE PREPARATION OF VOCLOSPORIN
#6METHOD FOR PREPARING A SALT OF ISOCYCLOSPORIN A
#7GREENHOUSE-BASED PRODUCTION OF FUNGAL-DERIVED MEDICINAL COMPOUNDS
#8SOLID STATE FORMS OF VOCLOSPORIN
#9CYCLOSPORIN DERIVATIVES AND USES THEREOF
#10CYCLOSPORINE COMPOSITIONS AND METHODS OF USE
#11COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF
#12METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES
#13CYCLOPHILIN INHIBITORS AND USES THEREOF
#14GENE THERAPY
#15HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF
#16PRODRUGS AND COMPOSITIONS FOR OPHTHALMOLOGY APPLICATIONS
#17CYCLOPHILIN INHIBITORS AND USES THEREOF
#18CYCLOSPORINE COMPOSITIONS AND METHODS OF USE
#19PREPARATION OF CYCLOSPORIN DERIVATIVES
#20Solid state forms of voclosporin
#21CYCLOSPORINE ANALOGUES
#22Cyclophilin inhibitors and uses thereof
#23CYCLOSPORIN DERIVATIVES AND USES THEREOF
#24Synthesis method of cyclosporine derivatives
#25COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF
#26Maleate of SCY-635 and uses thereof in medicine
#27METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES
#28Solid state forms of voclosporin
#29Crystalline form of compound and uses thereof in medicine
#30Cyclosporine compositions and methods of use
#31CRYSTALLINE FORM OF CYCLOSPORIN A, METHODS OF PREPARATION, AND METHODS FOR USE THEREOF
#32SUSTAINED ACTION FORMULATION OF CYCLOSPORIN FORM 2
#33Hybrid cyclic libraries and screens thereof
#34Method for producing cyclic organic compound
#35Method for improving retroviral transduction and gene editing in hematopoietic stem cells using cyclosporine h (CsH)
#36Gene Therapy
#37NOVEL PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF PERIODONTAL DISEASE
#38Hybrid cyclic libraries and screens thereof
#39SUSPENSIONS OF CYCLOSPORIN A FORM 2
#40METHOD FOR CONTROLLING IMPURITY OF CYCLOSPORIN A EYE GEL
#41COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF
#42CYCLOSPORIN A FORM 2 AND METHOD OF MAKING SAME
#43Methods and reagents for analyzing protein-protein interfaces
#44Methods and reagents for analyzing protein-protein interfaces
#45Skin-Penetrating Peptides and Compositions and Methods of Use Thereof
#46Lentiviral protein delivery system for RNA-guided genome editing
#47Hybrid cyclic libraries and screens thereof
#48MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES
#49AUTOCLAVABLE SUSPENSIONS OF CYCLOSPORIN A FORM 2
#50Macrocycles
#51Cyclosporin derivatives and uses thereof
#52CYCLOSPORIN DERIVATIVES WHEREIN THE MEBMT SIDECHAIN HAS BEEN CYCLIZED
#53Cyclosporine analogue mixtures and their use as immunomodulating agents
#54Quinolinium conjugates of cyclosporin
#55NON-IMMUNOSUPPRESSIVE CYCLOSPORIN DERIVATIVES AS ANTIVIRAL AGENTS
#56NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION
#57Methods and reagents for analyzing protein-protein interfaces
#58Gene therapy
#59Cyclosporin analogs
#60Process for the manufacture of cyclic undecapeptides
#61Cyclosporins modified on the MeBmt sidechain by heterocyclic rings
#62Cyclosporin a form 2 and method of making same
#63Autoclavable suspensions of cyclosporin A Form 2
#64Cyclosporine analogue molecules modified at amino acid 1 and 3
#65Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized
#66Compounds that participate in cooperative binding and uses thereof
#67Cyclosporin analogues for preventing or treating hepatitis C infection
#68Cyclosporin analogues for preventing or treating hepatitis C infection
#69Suspensions of cyclosporin A form 2
#70Hybrid cyclic libraries and screens thereof
#71CRYSTALLINE FORM OF CYCLOSPORIN A, METHODS OF PREPARATION, AND METHODS FOR USE THEREOF
#72Cyclosporine analogue mixtures and their use as immunomodulating agents
#73NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION
#74Cyclosporin analogues for preventing or treating hepatitis C infection
#75CYCLOSPORIN A ANALOGS
#76NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF
#77Cyclosporin analogs
#78Process for the Production of Cyclosporin-A Using the Fungus Tolypocladium Sp. Strain NRRL No.: 18950
#79NON-IMMUNOSUPPRESSIVE CYCLOSPORIN DERIVATIVES AS ANTIVIRAL AGENTS
#80Pharmaceutical formulations and their use in the treatment of periodontal disease
#81Cyclic peptides and use as medicines
#82NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS
#83Cyclosporin analogs
#84Cyclosporin analogues for preventing or treating hepatitis C infection
#85CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS
#86Modified drugs for use in liposomal nanoparticles
#87Suspensions of cyclosporin A form 2
#88Cyclosporin derivatives
#89Crystalline form of cyclosporine A, methods of preparation, and methods for use thereof
#90Cyclosporin A form 2 and method of making same
#91Synthesis of Cyclosporin Analogs
#92Cyclosporine A steroid conjugates
#93Deuterated Cyclosporine Analogs and Methods of Making the Same
#94ANTIVIRAL MACROCYCLES
#95MACROCYCLES
#96[N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
#97CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS
#98Cyclosporine analogue molecules modified at amino acid 1 and 3
#99Cyclic peptides and use as medicines
#100CYCLOSPORIN DERIVATIVES FOR TREATING INFLAMMATORY DISEASES AND CONDITIONS
#101Cyclosporin derivatives for the treatment and prevention of a viral infection
#102Cyclosporin A analogs
#103TREATMENT OF MECP-2 ASSOCIATED DISORDERS
#104Cyclosporin derivatives for the treatment and prevention of a viral infection
#105Cyclosporin derivatives and uses thereof
#106NONIMMUNOSUPPRESSIVE CYCLOSPORINE ANALOGUE MOLECULES
#107Sustained action formulation of cyclosporin form 2
#108Cyclosporin A form 2 and method of making same
#109Crystalline form of cyclosporine A, methods of preparation, and methods for use thereof
#1103-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION
#111Synthesis of Cyclosporin H
#112Modified drugs for use in liposomal nanoparticles
#113Deuterated Cyclosporine Analogs and Methods of Making the Same
#114Cyclosporin derivatives
#115Cyclosporin analogs
#116Cyclosporin Analogs
#117NOVEL CYCLOSPORIN ANALOGUES
#118Methods for detection of cyclosporin A
#119DEUTERATED CYCLOSPORINE ANALOGS AND METHODS OF MAKING THE SAME
#120Modified drugs for use in liposomal nanoparticles
#121NOVEL CYCLIC PEPTIDES
#122Method for processing microbiologically produced cyclic oligopeptides
#123SYNTHESIS OF CYCLOSPORIN ANALOGS
#124Proline substituted cyclosporin analogues
#125Cyclosporin analogues
#126Cyclosporin analogues
#127REGULATED TRANSCRIPTION OF TARGETED GENES AND OTHER BIOLOGICAL EVENTS
#128Regulated apoptosis
#129CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS
#130Cyclosporin derivatives for treating inflammatory diseases and conditions
#131Cyclic peptide compounds
#132Cyclosporin analogues
#133Cyclosporin analogues for preventing or treating hepatitis C infection
#134NOVEL PROCESS FOR THE PREPARATION OF CYCLOSPORIN DERIVATIVES
#135Macrocycles
#1363-Ether and 3-Thioether Substituted Cyclosporin Derivatives For the Treatment and Prevention of Hepatitis C Infection
#137Cyclic peptide compounds
#138Synthesis of Cyclosporin Analogs
#139Cyclosporin derivatives for treating ocular and dermal diseases and conditions
#140Deuterated Cyclosporine Analogs and Methods of Making the Same
#141Macrocyclic peptides
#142NOVEL CYCLIC PEPTIDES
#143Arylalkyl and heteroarylalkyl derivatives of cyclosporine A for the treatment and prevention of viral infection
#144Cyclic peptide compounds
#145METHODS FOR DETECTION OF CYCLOSPORIN A
#146Use of a cyclosporin for the treatment of hepatitis C infection and pharmaceutical composition comprising said cyclosporin
#147Regulated transcription of targeted genes and other biological events
#148CYCLOSPORIN ALKYNE ANALOGUES AND THEIR PHARMACEUTICAL USES
#149Cyclic peptide compound
#150Cyclosporine Analogue Mixtures and their Use as Immunomodulating Agents
#151Cyclic peptides
#152Cyclosporin alkynes and their utility as pharmaceutical agents
#153Processes for stereoselective synthesis of trans ISA247
#154Cyclosporin derivatives for the treatment of immune disorders
#155Process for the preparation of cyclosporin derivatives
#156Synthesis of cyclosporin analogs
#157Purification process
#158Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
#159Use of selected cyclosporins for the treatment of hepatitis C infection
#160Metabolites of cyclosporin analogs
#1613-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
#162Deuterated cyclosporine analogs and methods of making the same
#1633-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
#164Regulated transcription of targeted genes and other biological events
#165Cyclosporin alkynes and their utility as pharmaceutical agents
#166Cyclosporin alkyne analogues and their pharmaceutical uses
#167Cyclosporin analogues and their pharmaceutical uses
#168Methods of making deuterated cyclosporin analogs
#169Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases
#170Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases
#171Regulated apoptosis
#172Cyclosporine analogue mixtures and their use as immunomodulating agents
#173Deuterated cyclosporin analogs and their use as immunomodulating agents
#174Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol
#175Water soluble prodrugs of hindered alcohols
#176Purification process